Showing results (581-590 of 694) with videos related to
Sort By:
Pageof 70
Cancer|October 27, 2021
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapyMatteo Perrino, Tommaso De Pas, Silvia Bozzarelli, et al.International Journal of Molecular Sciences|December 11, 2025
Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging TreatmentRossella Cicchetti, Martina Basconi, Giulio Litterio, et al.JACS Au|November 28, 2025
Designing Peptide Fossils That Model the Evolution of the Bacterial Ferredoxin FoldBhanu P Jagilinki, Ian Campbell, Alexei M Tyryshkin, et al.Australian Health Review : a Publication of the Australian Hospital Association|November 27, 2010
'I don't know why they don't come': barriers to participation in cardiac rehabilitationMichelle L DiGiacomo, Sandra C Thompson, Julie S Smith, et al.ACS Applied Bio Materials|May 22, 2024
Optimizing Transfection Efficiency in CAR-T Cell Manufacturing through Multiple Administrations of Lipid-Based NanoparticlesFrancesca Giulimondi, Luca Digiacomo, Serena Renzi, et al.Oncogene|December 24, 2013
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cellsV Barbetti, A Morandi, I Tusa, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthKexin Yu, Maria Phung, Jiaming Liang, et al.Research and Reports in Urology|August 27, 2025
The Use of Artificial Intelligence in Urologic Oncology: Current Insights and ChallengesRossella Cicchetti, Daniele Amparore, Flavia Tamborino, et al.Nature|August 10, 2017
mRNA 3' uridylation and poly(A) tail length sculpt the mammalian maternal transcriptomeMarcos Morgan, Christian Much, Monica DiGiacomo, et al.Cancer Research Communications|December 12, 2022
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral NeurotoxicityMahesh R Nepal, Hanieh Taheri, Yang Li, et al.Pageof 70